MSK
Search
- Page Path
- HOME > Search
Review
- REVIEW] The role of laboratory diagnostics in emerging viral infections: the example of the Middle East respiratory syndrome epidemic
- Jasper F. W. Chan , Siddharth Sridhar , Cyril C. Y. Yip , Susanna K. P. Lau , Patrick C. Y. Woo
- J. Microbiol. 2017;55(3):172-182. Published online February 28, 2017
- DOI: https://doi.org/10.1007/s12275-017-7026-y
- 46 View
- 0 Download
- 22 Crossref
-
Abstract
- Rapidly emerging infectious disease outbreaks place a great strain on laboratories to develop and implement sensitive and specific diagnostic tests for patient management and infection control in a timely manner. Furthermore, laboratories also play a role in real-time zoonotic, environmental, and epidemiological investigations to identify the ultimate source of the epidemic, facilitating measures to eventually control the outbreak. Each assay modality has unique pros and cons; therefore, incorporation of a battery of tests using traditional culture-based, molecular and serological diagnostics into diagnostic algorithms is often required. As such, laboratories face challenges in assay development, test evaluation, and subsequent quality assurance. In this review, we describe the different testing modalities available for the ongoing Middle East respiratory syndrome (MERS) epidemic including cell culture, nucleic acid amplification, antigen detection, and antibody detection assays. Applications of such tests in both acute clinical and epidemiological investigation settings are highlighted. Using the MERS epidemic as an example, we illustrate the various challenges faced by laboratories in test development and implementation in the setting of a rapidly emerging infectious disease. Future directions in the diagnosis of MERS and other emerging infectious disease investigations are also highlighted.
-
Citations
Citations to this article as recorded by
- Scale-Up of COVID-19 Testing Services in NYC, 2020–2021: Lessons Learned to Maximize Reach, Equity and Timeliness
Lorna E. Thorpe, Sarah Conderino, Stefanie Bendik, Carolyn Berry, Nadia Islam, Rachel Massar, Michelle Chau, Rita Larson, Margaret M. Paul, Chuan Hong, Andrew Fair, Andrea R. Titus, Anna Bershteyn, Andrew Wallach
Journal of Urban Health.2024; 101(5): 913. CrossRef - An individual level infectious disease model in the presence of uncertainty from multiple, imperfect diagnostic tests
Caitlin Ward, Grant D. Brown, Jacob J. Oleson
Biometrics.2023; 79(1): 426. CrossRef - A comparative study of the policy response to COVID-19 in the ASEAN region: A dynamic simulated ARDL approach
Nihal Ahmed, Dilawar Khan, Judit Oláh, József Popp, Stefan Cristian Gherghina
PLOS ONE.2023; 18(1): e0276973. CrossRef - RNA Coronaviruses’ Outbreaks: Recent Progress on the SARS-CoV-2
Pandemic Diagnostic Tests, Vaccination and Therapeutics
Ghadeer A.R.Y. Suaifan, Bayan A. Alkhawaja, Aya A.M. Mohammed
Mini-Reviews in Medicinal Chemistry.2022; 22(4): 617. CrossRef - A computational tool for trend analysis and forecast of the COVID-19 pandemic
Henrique Mohallem Paiva, Rubens Junqueira Magalhães Afonso, Fabiana Mara Scarpelli de Lima Alvarenga Caldeira, Ester de Andrade Velasquez
Applied Soft Computing.2021; 105: 107289. CrossRef - Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges
Jaime Castillo-León, Ramona Trebbien, John J. Castillo, Winnie E. Svendsen
The Analyst.2021; 146(12): 3750. CrossRef - A network-based model to explore the role of testing in the epidemiological control of the COVID-19 pandemic
Yapeng Cui, Shunjiang Ni, Shifei Shen
BMC Infectious Diseases.2021;[Epub] CrossRef - Laboratory testing of SARS‐CoV, MERS‐CoV, and SARS‐CoV‐2 (2019‐nCoV): Current status, challenges, and countermeasures
Ying Yan, Le Chang, Lunan Wang
Reviews in Medical Virology.2020;[Epub] CrossRef - Laboratory verification of an RT‐PCR assay for SARS‐CoV‐2
Yingping Wu, Wei Xu, Zhiqiang Zhu, Xiaoping Xia
Journal of Clinical Laboratory Analysis.2020;[Epub] CrossRef - Current diagnostic tools for coronaviruses–From laboratory diagnosis to POC diagnosis for COVID‐19
Yung‐Chih Wang, Yi‐Tzu Lee, Ting Yang, Jun‐Ren Sun, Ching‐Fen Shen, Chao‐Min Cheng
Bioengineering & Translational Medicine.2020;[Epub] CrossRef - The Molecular Diagnosis Protocols of New Coronavirus (COVID-19); Specificity and Sensitivity an Overview
Abdullah Ahmed Hama, Othman Abdulrahman Mohammed, Fatima Mahmud Ali, Osama Hamid Shareef, Sardar Muhammad Wli, Sabiha Sharif, Syamand Ahmed Qadir
Kurdistan Journal of Applied Research.2020; : 13. CrossRef - Thoughts on What Chemists Can Contribute to Fighting SARS‐CoV‐2 – A Short Note on Hand Sanitizers, Drug Candidates and Outreach
Till Opatz, Joerg Senn‐Bilfinger, Clemens Richert
Angewandte Chemie.2020; 132(24): 9320. CrossRef - Thoughts on What Chemists Can Contribute to Fighting SARS‐CoV‐2 – A Short Note on Hand Sanitizers, Drug Candidates and Outreach
Till Opatz, Joerg Senn‐Bilfinger, Clemens Richert
Angewandte Chemie International Edition.2020; 59(24): 9236. CrossRef - An updated roadmap for MERS-CoV research and product development: focus on diagnostics
Cassandra Kelly-Cirino, Laura T Mazzola, Arlene Chua, Christopher J Oxenford, Maria D Van Kerkhove
BMJ Global Health.2019; 4(Suppl 2): e001105. CrossRef - Development and validation of different indirect ELISAs for MERS-CoV serological testing
Anwar M. Hashem, Sawsan S. Al-amri, Tagreed L. Al-subhi, Loai A. Siddiq, Ahmed M. Hassan, Maha M. Alawi, Rowa Y. Alhabbab, Salwa I. Hindawi, Osama B. Mohammed, Nabil S. Amor, Abdulaziz N. Alagaili, Ahmed A. Mirza, Esam I. Azhar
Journal of Immunological Methods.2019; 466: 41. CrossRef - International Biological Reference Preparations for Epidemic Infectious Diseases
Tommy Rampling, Mark Page, Peter Horby
Emerging Infectious Diseases.2019; 25(2): 205. CrossRef - MERS coronavirus outbreak: Implications for emerging viral infections
Awad Al-Omari, Ali A. Rabaan, Samer Salih, Jaffar A. Al-Tawfiq, Ziad A. Memish
Diagnostic Microbiology and Infectious Disease.2019; 93(3): 265. CrossRef - Inclusion of MERS‐spike protein ELISA in algorithm to determine serologic evidence of MERS‐CoV infection
Suvang Trivedi, Congrong Miao, Mohammad M. Al‐Abdallat, Aktham Haddadin, Sultan Alqasrawi, Ibrahim Iblan, Mohannad A. Nsour, Tarek Alsanouri, Sami S. Ali, Brian Rha, Susan I. Gerber, Daniel C. Payne, Azaibi Tamin, Natalie J. Thornburg
Journal of Medical Virology.2018; 90(2): 367. CrossRef - The structure of the C-terminal domain of the nucleoprotein from the Bundibugyo strain of the Ebola virus in complex with a pan-specific synthetic Fab
Malwina J. Radwańska, Mateusz Jaskółowski, Elena Davydova, Urszula Derewenda, Tsuyoshi Miyake, Daniel A. Engel, Anthony A. Kossiakoff, Zygmunt S. Derewenda
Acta Crystallographica Section D Structural Biology.2018; 74(7): 681. CrossRef - MERS, SARS and other coronaviruses as causes of pneumonia
Yudong Yin, Richard G. Wunderink
Respirology.2018; 23(2): 130. CrossRef - Hydrogel Tethering Enhances Interdomain Stabilization of Single-Chain Antibodies
Yijia Xiong, Nicole R. Ford, Karen A. Hecht, Guritno Roesijadi, Thomas C. Squier
Bioconjugate Chemistry.2017; 28(11): 2804. CrossRef - An Opportunistic Pathogen Afforded Ample Opportunities: Middle East Respiratory Syndrome Coronavirus
Ian Mackay, Katherine Arden
Viruses.2017; 9(12): 369. CrossRef
- Scale-Up of COVID-19 Testing Services in NYC, 2020–2021: Lessons Learned to Maximize Reach, Equity and Timeliness
First
Prev
TOP
